Acadia Healthcare Co IncACHC
ASignal's systematic analysis rates ACHC as Neutral.
Reflects the latest available analysis · analyzed Aug 20, 2026
The case on ACHC
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Positive gross margin (41.06%) indicating pricing power
- Operating cash flow of $210.52M suggests operational liquidity
- Current ratio of 1.57x and quick ratio of 1.35x reflect adequate short-term financial health
- Forward P/E of 15.02x is reasonable for Healthcare sector
- Negative free cash flow (-$104.96M) raises sustainability concerns
- Negative net margin (-33.44%) and return on equity (-41.45%) indicate poor profitability
- Declining earnings growth (YoY -63.6%) and flat revenue growth (-0.40%)
- MACD below signal line with negative histogram, indicating bearish momentum
- Price below SMA20 and SMA50, signaling downtrend
See the full verdict on ACHC
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes ACHC
Most investors never get a second opinion, let alone several. ASignal runs ACHC past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.